Controversies in Neurology
January 2008

Botulinum Toxin Type A for the Treatment of HeadacheWhy We Say Yes

Author Affiliations

Author Affiliations: Jefferson Headache Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.


E. S.RoachMD


Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2008

Arch Neurol. 2008;65(1):146-149. doi:10.1001/archneurol.2007.20

Botulinum toxin type A (BoNT-A) has long been used to treat disorders associated with increased muscle tone. Support for an analgesic effect of BoNT-A independent of its muscle relaxation effect came from clinical observations that some patients with dystonia obtained pain relief before they obtained improvement in muscle tone.1 Injections of BoNT-A were discovered serendipitously to alleviate migraine headache when they were given for the treatment of facial wrinkles.2 After several open-label studies showed that BoNT-A might have efficacy in headache treatment, randomized controlled trials were initiated to investigate this issue further.3 New scientific data have provided insight into mechanisms by which BoNT-A may exert its analgesic effect. In our discussion, we focus on clinical data obtained from randomized controlled trials.

First Page Preview View Large
First page PDF preview
First page PDF preview